Six Months Till Sunrise: CMS Allows Extra Time For Firms To Collect Physicians Payment Data
This article was originally published in The Pink Sheet Daily
Executive Summary
Drug makers get three more months to comply than the proposed rule offered; firms must send the data by March 31, 2014, to CMS, which plans to make the information available on a public website by Sept. 30, 2014.
You may also be interested in...
Sunshine Act Deadline Is Still Cloudy As Registration Not Yet Available
Physician payment data is coming due, but stakeholders continue to press CMS for clarity on the deadline for the first set of information since conflicting instructions are on the agency’s website.
Physician Sunshine Rule Needs Longer Lead Time Before Implementation, PhRMA Says; Scope Challenged By CROs
The Pharmaceutical Research and Manufacturers of America seeks at least a six-month lead time before implementation in comments to CMS. The Association for Clinical Research Organizations takes issue with including payments for “legitimate” research in the rulemaking at all.
Sunshine Proposal Allows Lump Sum Reporting Of Research Payments To Institutions
CMS-proposed rule would allow companies to report a single figure for research payments to institutions and attribute it to the principal investigator(s), although the agency will not include it when computing physicians’ total receipts from industry. The agency wants more details on what payments are for, calling on firms to break them down by category when more than one expense type is included in a single payment.